Research shows sotagliflozin is the first medication of its kind to significantly reduce both heart attacks and strokes
Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with ...
New drug delivery method promises long-lasting glaucoma relief
Researchers at the University of Toronto see a future where a single injection under the eyelid could replace months of daily ...